Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Disclosure Under Regulation-30

 With reference to the disclosure made on 12th January, 2022, this is to inform you that Kothari Fermentation and Biochem Limited has launched its new product Yeast Extract Powder and Mono Oligo Saccharides (Mannan and Beta Glucan). This product is mainly used in Pharmaceutical sector and also suitable for food and food stuff, dietary foods, beverages, soups, seasonings, low calorie food, Nutritional filler, Microbial growth media, Fermentation substrate Biotech, Biotech Research, etc.
22-04-2022
Bigul

KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Statement Of Investor Complaints For The Quarter Ended March 2022 (Revised)

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Kavita TanwarDesignation :- Company Secretary and Compliance Officer
19-04-2022
Bigul

KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligations & Disclosure Requirements Regulations, 2015 For The Year Ended 31.03.2022.

 Pursuant to regulation 7 (3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Please find herewith enclosed certificate dated 7th April, 2022, certifying that all activities in relation to both physical and electronic share transfer facility (Dematerialisation & Rematerialisation) are maintained by the Company's Registrar and Share Transfer Agent M/s Abhipra Capital Limited (SEBI Registration Number: INR 000003829).
09-04-2022
Bigul

KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Statement Of Investor Complaints For The Quarter Ended March 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Kavita TanwarDesignation :- Company Secretary and Compliance Officer
09-04-2022
Bigul

KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are enclosing herewith a copy of the Certificate received from M/s Abhipra Capital Limited, the Registrar and share Transfer Agent of the Company, for the quarter ended March 31, 2022.
09-04-2022
Bigul

KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayKOTHARI FERMENTATION & BIOCHEM LTD. 2CINL72411DL1990PLC042502 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: KAVITA TANWAR Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: kavitatanwar@kothariyeast.in Name of the Chief Financial Officer: ARUN KUMAR SEKHANI Designation: CHIEF FINANCIAL OFFICER EmailId: arunsekhani@kothariyeast.in Date: 05/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
05-04-2022
Bigul

KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Closure of Trading Window

 This is to inform you that pursuant to the provisions of the Securities And Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's code of conduct for regulating, monitoring and reporting of trading by Insiders, the Trading Window for dealing in the Equity Shares of the company by Designated Persons, is closed from April 1, 2022 upto the completion of 48 hours after the declaration of the Audited Financial Results of the company for the quarter/year ended March 31, 2022.
28-03-2022
Bigul

KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Intimation To Shareholders Holding Shares In Physical Mode.

 Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Please find enclosed herewith a copy of the letter sent to the shareholders holding shares in physical mode in compliance with the SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2021/655 dated November 3, 2021 and SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2021/687 dated December 14, 2021.
19-02-2022
Bigul

KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Board Meeting Outcome for Outcome Of Board Meeting

 Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at their Meeting held on 14th February, 2022 considered and approved, interalia, the Unaudited Financial Results along with Limited Review Report of the Company for the quarter and nine months ended on 31st December, 2021.
14-02-2022
Bigul

KOTHARI FERMENTATION & BIOCHEM LTD. - 507474 - Board Meeting Intimation for NOTICE OF BOARD MEETING

 KOTHARI FERMENTATION & BIOCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company will be held on Monday, the 14th day of February, 2022 at the Registered Office of the Company at 16, Community Centre, First Floor, Saket, New Delhi - 110017, inter-alia to consider and approve the Unaudited Financial Results for the quarter ended on 31st December, 2021.
04-02-2022
Next Page
Close

Let's Open Free Demat Account